Literature DB >> 24792656

High-quality breast MRI.

R Edward Hendrick1.   

Abstract

Breast magnetic resonance imaging (MRI) demands the competing factors of high spatial resolution, good temporal resolution, high signal-to-noise ratios, and complete bilateral breast coverage. Achieving these competing factors requires modern MRI equipment with high magnetic field strength and homogeneity, high maximum gradient strength with short rise times, dedicated multichannel bilateral breast coils with prone patient positioning, and 3D (volume) gradient-echo MRI pulse sequences with short TR, short TE, high spatial resolution, and reasonably short acquisition times. This article discusses the equipment and pulse sequences needed to achieve high-quality breast MRI and summarizes requirements of the ACR Breast MRI Accreditation Program.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer detection; Contrast agent; Spatial resolution; Technical quality; Temporal resolution

Mesh:

Substances:

Year:  2014        PMID: 24792656     DOI: 10.1016/j.rcl.2013.12.002

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  2 in total

1.  Fabrication and evaluation of bilateral Helmholtz radiofrequency coil for thermo-stable breast image with reduced artifacts.

Authors:  Young Han Lee; Kyu-Ho Song; Jaemoon Yang; Won Jun Kang; Keum Sil Lee; Min Jung Kim; Eun-Kyung Kim; Dan Heo; Bo-Young Choe; Jin-Suck Suh
Journal:  J Appl Clin Med Phys       Date:  2021-12-01       Impact factor: 2.102

2.  Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).

Authors:  Carlos Canelo-Aybar; Alvaro Taype-Rondan; Jessica Hanae Zafra-Tanaka; David Rigau; Axel Graewingholt; Annette Lebeau; Elsa Pérez Gómez; Paolo Giorgi Rossi; Miranda Langendam; Margarita Posso; Elena Parmelli; Zuleika Saz-Parkinson; Pablo Alonso-Coello
Journal:  Eur Radiol       Date:  2021-05-30       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.